Abdominal CancerNCT07357350
Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer
An observational study of Abdominal Cancer, run by Aga Khan University.
Trial summary
The goal of this prospective observational study is to observe the effectiveness of pain management interventions in patients with abdominal and pelvic cancer pain. The main question[s] it aims to answer are: The effectiveness of pain management interventions. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Abdominal Cancer
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 16 Jan 2026to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with chronic pain due to abdominal and pelvic cancer.
Who may be able to join
- Patients with chronic pain due to abdominal and pelvic cancer
- Both Male and Female
- Ages18-65 years
- Patients who with recurrence or metastasis
Who cannot join
- Patients who refuse to give consent
- Patients who were lost to follow up after initial visit or assessment
- History of severe depression or psychiatric illness
- History of surgical procedure due to cancer
- Patients with DNR code
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer in a Tertiary Care Hospital: A Prospective Observational Study
The goal of this prospective observational study is to observe the effectiveness of pain management interventions in patients with abdominal and pelvic cancer pain.
The main question[s] it aims to answer are:
- The effectiveness of pain management interventions.
- The frequency of pain intervention procedures and side effects and complications of pain management interventions
- Conditions
- Abdominal Cancer
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient reported NRS score
Numeric Rating Score from 0 (no pain)- 10 (severe pain)
Measured: First visit and then at 3 months
Secondary outcomes (1)
Number of patients
Number of patients on whom the intervention is performed.
Measured: From 2 weeks to 3 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jan 2026
- Study start16 Jan 2026 (estimated)
- Primary completion15 Oct 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abdominal CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Aga Khan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ali Sarfraz Siddiqui, Aga Khan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07357350
- Sponsor's protocol ID
- 2025-12177-38695
- Other IDs
- 2025
- Status last verified
- Jan 2026
- First submitted
- 15 Jan 2026
- Last updated
- 22 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer in a Tertiary Care Hospital: A Prospective Observational Study
- ClinicalTrials.gov ID
- NCT07357350
- Acronym / sponsor ID
- 2025-12177-38695
- Conditions
- Abdominal Cancer
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Aga Khan UniversityUniversity, hospital or other
- Study start
- 16 Jan 2026 (estimated)
- Primary completion
- 15 Oct 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 22 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this prospective observational study is to observe the effectiveness of pain management interventions in patients with abdominal and pelvic cancer pain.
The main question[s] it aims to answer are:
- The effectiveness of pain management interventions.
- The frequency of pain intervention procedures and side effects and complications of pain management interventions
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with chronic pain due to abdominal and pelvic cancer.
Key inclusion criteria (4 listed)
- Patients with chronic pain due to abdominal and pelvic cancer
- Both Male and Female
- Ages18-65 years
- Patients who with recurrence or metastasis
Key exclusion criteria (5 listed)
- Patients who refuse to give consent
- Patients who were lost to follow up after initial visit or assessment
- History of severe depression or psychiatric illness
- History of surgical procedure due to cancer
- Patients with DNR code
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Patient reported NRS score
Time frame: First visit and then at 3 months
Numeric Rating Score from 0 (no pain)- 10 (severe pain)
1 secondary outcome
Number of patients
Time frame: From 2 weeks to 3 months.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Abdominal Cancer
RecruitingPhase 2
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
Not yet recruiting
Nurse-Led Prehabilitation Before Major Abdominal Cancer Surgery
Colorectal Cancer
RecruitingPhase 1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC)
RecruitingPhase 1
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Peritoneal Mesothelioma, Peritoneal Carcinomatosis
RecruitingPhase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Abdominal Cancer, run by Aga Khan University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ali Sarfraz Siddiqui, MBBS, FCPS (00922134864397 ext. 4397, sarfraz.siddiqui@aku.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient reported NRS score (time frame: First visit and then at 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.